(Press-News.org) LA JOLLA, Calif., October 18, 2010 – Lymphoma is a cancer of the immune system. White blood cells divide again and again, spreading abnormally throughout the body. Lymphomas can arise from two types of white blood cells, T cells or B cells, which divide uncontrollably when the molecular mechanisms that keep them in check go awry. A new study led by Robert Rickert, Ph.D., professor and director of the Inflammatory Diseases Program at Sanford-Burnham Medical Research Institute (Sanford-Burnham), explores the roles of two enzymes, called SHIP and PTEN, in B cell growth and proliferation. The results, published online on October 18 in The Journal of Experimental Medicine, show that SHIP and PTEN act cooperatively to suppress B cell lymphoma. This new information could impact several anti-lymphoma therapies currently in development.
"PTEN usually gets all the attention," Dr. Rickert explained. "But here we show for the first time that SHIP is also a major tumor suppressor in B cells."
T cells destroy infected cells, while B cells produce antibodies to neutralize foreign particles. To maintain enough of these cells to mount an immune response, but not so many that lymphomas develop, PTEN and SHIP keep a damper on PI3K, an enzyme that promotes cellular growth, survival and proliferation. PI3K signaling is altered in a number of different cancers. If PTEN is missing in T cells, the damper is removed, cells grow out of control and T cell lymphomas result. Surprisingly, this study showed that B cells deficient in either PTEN or SHIP are fine. But if mouse B cells are engineered to lack both PTEN and SHIP, lethal B cell abnormalities develop.
Could PTEN and SHIP mutations actually lead to lymphoma in humans? In an earlier collaborative study with Michael David, Ph.D., at the University of California, San Diego, Dr. Rickert and colleagues showed that inflammation – such as occurs after infection or injury – reduces SHIP expression. The current study suggests that while PTEN mutation in B cells alone might not cause harm, a single mutation plus inflammation could be a double whammy that gives rise to lymphoma.
"People often talk about one gene relating to one cancer," Dr. Rickert said. "But cancer is multigenic – it takes multiple hits to subvert a cell from normal to abnormal. Here we have a model showing how that can happen in B cells."
In addition to increasing our understanding of B cell biology, this research has implications for lymphoma treatments currently in development. One such treatment targets drug-resistant B cells by depleting the body of BAFF, a compound that promotes their survival. In this new B cell lymphoma model, however, Dr. Rickert and colleagues found that B lymphoma cells still proliferate without BAFF.
On a more positive note, this study supports the development of anti-lymphoma drugs that mimic PTEN and SHIP activity by inhibiting PI3K. "Several companies are making PI3K inhibitors to treat certain kinds of lymphomas," Dr. Rickert said. "I think this system could provide a useful new preclinical model to study PI3K-dependent B cell malignancies. "
INFORMATION:
This study was funded by the National Heart, Lung and Blood Institute (NHLBI), the National Institute of Allergy and Infectious Diseases (NIAID) and the National Cancer Institute (NCI) at the National Institutes of Health (NIH). For more information about Sanford-Burnham research, visit http://beaker.sanfordburnham.org.
Original paper
Meletic AV, Anzelon-Mills A, Mills DM, Omori SA, Pedersen IM, Shin D-M, Ravetch JV, Bolland S, Morse III HC, Rickert R. Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases. Journal of Experimental Medicine. Published online October 18, 2010.
About Sanford-Burnham Medical Research Institute
Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham, with operations in California and Florida, is one of the fastest-growing research institutes in the country. The Institute ranks among the top independent research institutions nationally for NIH grant funding and among the top organizations worldwide for its research impact. From 1999 – 2009, Sanford-Burnham ranked #1 worldwide among all types of organizations in the fields of biology and biochemistry for the impact of its research publications, defined by citations per publication, according to the Institute for Scientific Information. According to government statistics, Sanford-Burnham ranks #2 nationally among all organizations in capital efficiency of generating patents, defined by the number of patents issued per grant dollars awarded.
Sanford-Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is especially known for its world-class capabilities in stem cell research and drug discovery technologies. Sanford-Burnham is a nonprofit public benefit corporation. For more information, please visit www.sanfordburnham.org.
SHIP protein identified as a B-cell tumor suppressor
2010-10-20
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Professional sports persons should drink more water
2010-10-20
Top sports persons must always perform to their maximum capacity, making them the most vulnerable to the effects of dehydration. Now, a new study conducted by researchers from the Universidad de Castilla la Mancha (UCLM) reveals that 91% of professional basketball, volleyball, handball and football players are dehydrated when they begin their training sessions.
"Dehydration negatively affects sporting performance, even when the level of dehydration is low (such as a 2% loss of body weight through perspiration)", UCLM researcher and author of the article Ricardo Mora-Rodríguez ...
More than 200 new snails of the same genus described in a single study
2010-10-20
Two world experts in micro molluscs, Anselmo Peñas and Emilio Rolán, have made an unprecedented description in a scientific publication of a combined total of 209 snail species. Commissioned by the National Museum of Natural History in Paris, the study was unveiled in September in the French capital, and it covers the most new species from a single genus of any study to date.
"Never have so many species from a single genus, nor even from a single family, been described in one single study", Anselmo Peñas, lead author of the collaborative monograph between the National ...
Study reveals how sex hormones influence right heart function
2010-10-20
In the largest human study to date on the topic, researchers have uncovered evidence of the possible influence of human sex hormones on the structure and function of the right ventricle (RV) of the heart.
The researchers found that in women receiving hormone therapy, higher estrogen levels were associated with higher RV ejection fraction and lower RV end-systolic volume — both measures of the RV's blood-pumping efficiency — but not in women who were not on hormone therapy, nor in men. Conversely, higher testosterone levels were associated with greater RV mass and larger ...
Air pollution exposure increases risk of severe COPD
2010-10-20
Long term exposure to low-level air pollution may increase the risk of severe chronic obstructive pulmonary disease (COPD), according to researcher s in Denmark. While acute exposure of several days to high level air pollution was known to be a risk factor for exacerbation in pre-existing COPD, until now there had been no studies linking long-term air pollution exposure to the development or progression of the disease.
The research was published online ahead of the print edition of the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
"Our ...
Adiponectin shows potential in blocking obesity-related carcinogenesis
2010-10-20
A research team from Emory University School of Medicine investigated the role between adiponectin and leptin in obesity-related carcinogenesis. Their findings, published in the November issue of Hepatology, suggest that the protein hormone adiponectin has potential for inhibiting the oncogenic actions of leptin, namely in hepatocellular carcinoma (HCC), and could offer a promising therapy for the disease.
Obesity is on the rise and is associated with increased risk and progression of a number of cancers including colon, prostate, breast, and liver cancers. The World ...
Visceral adiposity index directly correlated to viral load in genotype 1 chronic hepatitis C
2010-10-20
Researchers at the University of Palermo in Italy provide the evidence that a higher visceral adiposity index score—a new index of adipose dysfunction—has a direct correlation with viral load and is independently associated with both steatosis and necroinflammatory activity in patients with genotype 1 chronic hepatitis C (G1 CHC). Details of this study are available in the November issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
According to public health surveillance data gathered ...
Experts discuss S-equol data at ninth international symposium on role of soy
2010-10-20
Washington, DC (Oct. 19, 2010) The latest research into the health effects and safety of a soy-based compound called S-equol was described in talks and presentations by experts at a special session on Tuesday, Oct. 19 during the Ninth International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment, held Oct. 16 to 19 in Washington, D.C.
S-equol is a compound resulting -- when certain bacteria are present in the digestive track -- from the natural metabolism, or conversion, of daidzein, an isoflavone found in whole soybeans. ...
Experiments find bias in way analysts view firms led by black grads of prestigious universities
2010-10-20
Analysts examining a firm and the qualifications of its top management team discount the educational background of African American managers who graduated from prestigious universities while accepting the qualifications of white managers with the same college credentials, according to two experiments reported in the current issue of Organization Science, a journal of the Institute for Operations Research and the Management Sciences (INFORMS®).
"We found that possessing high educational prestige was less beneficial for firms led by African Americans than for firms with ...
Novel regulatory process for T cells may help explain immune system diseases
2010-10-20
CINCINNATI - A newly identified regulatory process affecting the biology of immune system T cells should give scientists new approaches to explore the causes of autoimmunity and immune deficiency diseases.
In findings posted online ahead of publication in Proceedings of the National Academy of Sciences (PNAS), scientists at Cincinnati Children's Hospital Medical Center report a novel process of coordinated cellular communications vital to the maintenance of T cells. If the process breaks down, T cells proliferate rapidly and die off. This could disrupt the immune system's ...
Friends share personal details to strengthen relationships in United States, but not in Japan
2010-10-20
In the United States, friends often share intimate details of their lives and problems. However, such self-disclosure is much less common in Japan. A new study by an American researcher living in Japan finds that this may be because of the different social systems in the two countries, and in particular the extent to which there are opportunities to make new friends.
"At first, it seemed strange that in Japan, people didn't open up and share a lot about themselves with each other," says Joanna Schug of Hokkaido University. "But Japanese often look at Americans and think, ...